Nureca Quarterly Results for Trading Insights

NURECA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹4 Cr
QSept 2025
Quarterly Results

Nureca Quarterly Results Key Highlights

  • Revenue of ₹40 Cr in Sept 2025 (+17.6% vs Mar 2025, +17.6% vs Sept 2024)
  • Net Profit of ₹4 Cr in Sept 2025 (+33.3% vs Mar 2025, +500.0% vs Sept 2024)
  • EBITDA of ₹6 Cr in Sept 2025 (+100.0% vs Mar 2025)
  • Operating Margin of 9.0% in Sept 2025 (+5.0pp vs Mar 2025)
  • Earnings Per Share of ₹3.63 in Sept 2025 (+47.0% vs Mar 2025)

Nureca Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 40 34 37 42 34 17.6% 17.6%
Net Profit (₹ Cr) 4 3 1 4 -1 - -
EBITDA (₹ Cr) 6 3 2 5 1 - -
EPS (₹) 3.63 2.47 0.81 3.91 -0.48 - -
Operating Margin (%) 9.0% 4.0% -2.0% 8.0% -8.0% - -

Nureca Share Price Trend Around Quarterly Results

Visualize Nureca's 1-year price movement across quarterly results — ideal for logging trades in Nureca share price chart using Tickjournal. All values in ₹.

Related Pages for Nureca

Additional stock information and data for NURECA

NURECA P/B ratio history
NURECA P/E comparison
Nureca financial data
NURECA stock valuation models
NURECA ownership pattern
Nureca market cap
NURECA price range

Profitability Ratios

Profit Margin 10.0%
EBITDA Margin 15.0%
Operating Margin 9.0%
ROE (Annual) 8.2%

Balance Sheet Highlights

Total Assets ₹210 Cr
Total Equity ₹194 Cr
Current Assets ₹190 Cr
Current Liabilities ₹3 Cr

Cash Flow Analysis

Operating Cash Flow ₹-19 Cr
Investing Cash Flow ₹8 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹-11 Cr

Current Market Data

Current Price ₹282.25
Exchange NSE
Last Updated Mar 02, 2026

Revenue Trend (₹ Cr)

Dec 2025 42
Jun 2025 37
Mar 2025 34
Sept 2025 40

Net Profit Trend (₹ Cr)

Dec 2025 4
Jun 2025 1
Mar 2025 3
Sept 2025 4

Operating Margin Trend (%)

Dec 2025 8.0%
Jun 2025 -2.0%
Mar 2025 4.0%
Sept 2025 9.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Nureca quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹416,764.48 Cr 1752.5 14,875 3,125 +10.8% - 21.0% 134.8
Divis Laboratories
Sept 2025 		₹170,125.54 Cr 6403.5 2,860 689 +7.1% - 24.1% 246.6
Torrent Pharmaceuti…
Sept 2025 		₹146,658.56 Cr 4369.2 3,219 591 +11.3% - 18.4% 249.1
Cipla
Sept 2025 		₹109,178.44 Cr 1351.6 7,716 1,353 +12.0% - 17.5% 80.8
Dr Reddys Laborator…
Sept 2025 		₹107,358.50 Cr 1294.4 9,135 1,337 +1.1% - 14.6% 80.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores